Apnea of Prematurity
2
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
1
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Human BioSciencesWV - Martinsburg
2 programs1
1
Caffeine citratePhase 41 trial
Caffeine CitratePhase 31 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Human BioSciencesCaffeine citrate
Human BioSciencesCaffeine Citrate
Angeles TherapeuticsVibration
Clinical Trials (3)
Total enrollment: 920 patients across 3 trials
MRI and Neurodevelopment in Preterm Infants Following Administration of High-Dose Caffeine
Start: Nov 2008Est. completion: Dec 201574 patients
Phase 4Completed
Moderately Preterm Infants With Caffeine at Home for Apnea (MoCHA) Trial
Start: Feb 2019Est. completion: Mar 2023827 patients
Phase 3Terminated
Non-invasive Intervention for Apnea of Prematurity
Start: Oct 2014Est. completion: Feb 201619 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs, potential near-term approvals
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.